Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Singaporean (SGX) Pharma Industry Analysis

UpdatedApr 03, 2026
DataAggregated Company Financials
Companies4
  • 7D-0.8%
  • 3M6.8%
  • 1Y32.8%
  • YTDn/a

In the last week, Pharma has been flat. The past year has been better, since the industry has gained 34% in that time. Earnings are forecast to grow by 4.0% annually.

Industry Valuation and Performance

Has the Singaporean Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 03 Apr 2026S$4.0bS$422.7mS$264.6m15.1x15.2x9.5x
Sun, 01 Mar 2026S$4.0bS$450.7mS$252.2m14.8x15.9x8.9x
Tue, 27 Jan 2026S$3.8bS$451.3mS$258.8m14.6x14.6x8.4x
Thu, 25 Dec 2025S$3.6bS$451.4mS$258.8m14x14x8x
Sat, 22 Nov 2025S$3.5bS$451.4mS$258.8m13.4x13.5x7.7x
Mon, 20 Oct 2025S$3.4bS$451.3mS$258.8m13.1x13.1x7.5x
Wed, 17 Sep 2025S$3.3bS$451.1mS$258.7m12.7x12.8x7.4x
Fri, 15 Aug 2025S$3.3bS$457.4mS$248.6m12.5x13.1x7.1x
Sun, 13 Jul 2025S$2.8bS$459.3mS$230.2m10.4x12.2x6.1x
Tue, 10 Jun 2025S$2.7bS$459.4mS$230.2m9.4x11.8x5.9x
Thu, 08 May 2025S$2.7bS$459.3mS$230.2m11.2x11.6x5.8x
Sat, 05 Apr 2025S$3.0bS$459.7mS$230.3m12.4x12.8x6.4x
Mon, 03 Mar 2025S$2.9bS$459.8mS$230.3m12.1x12.8x6.4x
Wed, 29 Jan 2025S$2.7bS$449.4mS$232.7m9.6x11.4x5.9x
Fri, 27 Dec 2024S$2.6bS$449.4mS$232.7m9.4x11x5.7x
Sun, 24 Nov 2024S$2.6bS$449.4mS$232.7m9.6x11.2x5.8x
Tue, 22 Oct 2024S$2.5bS$448.3mS$232.7m9.5x10.9x5.7x
Thu, 19 Sep 2024S$2.5bS$448.2mS$232.7m9.4x10.8x5.6x
Sat, 17 Aug 2024S$2.4bS$438.2mS$233.4m9.3x10.2x5.4x
Mon, 15 Jul 2024S$2.4bS$431.9mS$216.0m9.7x11.1x5.6x
Wed, 12 Jun 2024S$2.3bS$432.0mS$216.0m9.5x10.6x5.3x
Fri, 10 May 2024S$2.2bS$417.3mS$214.6m9.7x10.5x5.4x
Sun, 07 Apr 2024S$2.3bS$417.2mS$214.6m10x10.7x5.5x
Tue, 05 Mar 2024S$2.3bS$417.2mS$214.6m9.9x10.6x5.5x
Thu, 01 Feb 2024S$2.2bS$371.1mS$172.1m12.4x12.9x6x
Sat, 30 Dec 2023S$2.3bS$371.0mS$172.1m12.7x13.3x6.2x
Mon, 27 Nov 2023S$5.4bS$1.6bS$310.7m12.3x17.4x3.5x
Wed, 25 Oct 2023S$5.0bS$1.5bS$326.6m9.9x15.2x3.2x
Fri, 22 Sep 2023S$5.3bS$1.5bS$326.8m10.1x16.2x3.4x
Sun, 20 Aug 2023S$5.4bS$1.5bS$314.0m10.2x17.1x3.5x
Tue, 18 Jul 2023S$6.1bS$1.5bS$289.9m10.8x21x4x
Thu, 15 Jun 2023S$6.3bS$1.5bS$290.1m10.6x21.8x4.1x
Sat, 13 May 2023S$6.5bS$1.6bS$294.6m11.3x22x4.1x
Mon, 10 Apr 2023S$6.0bS$1.6bS$268.8m11.5x22.5x3.9x
Price to Earnings Ratio

22.5x


Total Market Cap: S$6.0bTotal Earnings: S$268.8mTotal Revenue: S$1.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Singaporean Pharma Industry Price to Earnings3Y Average 13.8x202420252026
Current Industry PE
  • Investors are optimistic on the Singaporean Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 15.4x which is higher than its 3-year average PE of 13.9x.
  • The 3-year average PS ratio of 5.8x is lower than the industry's current PS ratio of 9.6x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have declined 35% per year.
  • This means that the cost of doing business could be reducing since sales have declined but profits have remained steady.

Industry Comparison

How does Singaporean Pharma compare with similar industries?

SG Market1.11%
Healthcare0.59%
Pharma-0.76%
Pharma-0.76%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available

Latest News

H02
S$16.77
Haw Par
7D
-0.7%
1Y
27.9%
42C
S$0.20
iX Biopharma
7D
-0.5%
1Y
994.4%
1J5
S$0.30
Hyphens Pharma International
7D
-3.2%
1Y
7.0%